A detailed history of Hurley Capital, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Hurley Capital, LLC holds 128 shares of LLY stock, worth $130,777. This represents 0.06% of its overall portfolio holdings.

Number of Shares
128
Previous 114 12.28%
Holding current value
$130,777
Previous $89 Million 9.96%
% of portfolio
0.06%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$625.65 - $812.69 $8,759 - $11,377
14 Added 12.28%
128 $97.9 Million
Q2 2025

Aug 13, 2025

BUY
$713.71 - $898.95 $7,850 - $9,888
11 Added 10.68%
114 $89 Million
Q1 2025

May 07, 2025

SELL
$725.72 - $929.72 $72,572 - $92,972
-100 Reduced 49.26%
103 $85.2 Million
Q4 2024

Feb 12, 2025

BUY
$727.2 - $932.06 $147,621 - $189,208
203 New
203 $162 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Hurley Capital, LLC Portfolio

Follow Hurley Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hurley Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hurley Capital, LLC with notifications on news.